Acute Kidney Injury Management Strategies

Diagnostic Criteria and Definitions

• AKI is diagnosed when serum creatinine increases by ≥0.3 mg/dL within 48 hours or ≥50% from baseline, or when urine output is reduced below 0.5 mL/kg/h for >6 hours 1
• Oliguric AKI is characterized by urine output <0.5 mL/kg/h for >6 hours 2
• Both types of AKI can occur in all etiologies of AKI (pre-renal, intrinsic, post-renal) 3

Initial Management

• Immediately investigate the cause of AKI to prevent progression 4
• Discontinue all diuretics regardless of AKI type 4, 3
• Consider stopping beta-blockers, especially in hemodynamically unstable patients 4
• Identify and treat precipitating factors, including screening for infections 1
• Discontinue all nephrotoxic medications (NSAIDs, vasodilators) 4, 5

Specific Management for Oliguric AKI

• Volume replacement should be more aggressive, guided by the cause and severity of fluid loss 4
• For patients with diarrhea or excessive diuresis, administer crystalloids 4
• For patients with GI bleeding, give packed red blood cells to maintain hemoglobin 7-9 g/dL 4
• In cases with no obvious cause and AKI stage >1A, administer 20% albumin solution at 1 g/kg (maximum 100g) for two consecutive days 4, 3

Monitoring and Follow-up

• Closely monitor urine output, serum creatinine, electrolytes, and acid-base status in both types 4
• Use urinary biomarkers when available to distinguish between different types of AKI (e.g., urinary NGAL to differentiate ATN from hepatorenal syndrome) 4
• In patients with tense ascites and AKI, therapeutic paracentesis should be performed with albumin infusion 4

Special Considerations

• In patients with cirrhosis, AKI management follows similar principles but with greater emphasis on albumin administration 1
• Avoid the "triple whammy" combination of renin-angiotensin system inhibitors, diuretics, and NSAIDs in all AKI patients 5
• For contrast-associated AKI, recent evidence suggests that risks with modern contrast agents are lower than previously thought, but caution is still warranted in high-risk patients 6

Prevention Strategies

• Implement nephrotoxin stewardship programs to reduce exposure to kidney-damaging medications 5
• Avoid excessive or unmonitored diuretics that can precipitate AKI 1
• Ensure adequate volume expansion when performing procedures that may compromise renal perfusion 1
• Minimize duration and dose of nephrotoxin exposure when these agents cannot be avoided 5